Effect of reminder devices on medication adherence: the REMIND randomized clinical trial.

Patterns and predictors of persistent opioid use following hip or knee arthroplasty.

Clinical outcomes of concomitant use of warfarin and selective serotonin reuptake inhibitors: a multidatabase observational cohort study.

Predicting 1-year statin adherence among prevalent users: a retrospective cohort study.

Rationale and design of the Medication adherence Improvement Support App For Engagement - Blood Pressure (MedISAFE-BP) trial.

Impact of hospitalization on medication adherence estimation in claims data.

Association between patient-centered medical homes and adherence to chronic disease medications: a cohort study.

Longitudinal patterns of spending enhance the ability to predict costly patients: a novel approach to identify patients for cost containment.

Impact of an interaction between clopidogrel and selective serotonin reuptake inhibitors.

Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data.

Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.

Strength of evidence for labeled dosing recommendations in renal impairment.

Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge.

Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial.

Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women.

Potentially disruptive life events: what are the immediate impacts on chronic disease management? A case-crossover analysis.

Impact of Massachusetts health reform on enrollment length and health care utilization in the unsubsidized individual market.

Who were the early adopters of dabigatran?: an application of group-based trajectory models.

Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction.

Limiting the duration of opioid prescriptions balancing excessive prescribing and the effective treatment of pain.

Prevalence, effectiveness, and characteristics of pharmacy-based medication synchronization programs.

Brief Report: Intensification to triple therapy after treatment with nonbiologic disease-modifying antirheumatic drugs for rheumatoid arthritis in the United States from2009 to2014.

Medicaid prescription limits: policy trends and comparative impact on utilization.

Text messaging and patient engagement in an increasingly mobile world.

Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians.

Prospective benefit-risk monitoring of new drugs for rapid assessment of net favorability in electronic health care data.

Evaluating Cardiovascular Health Disparities Using Estimated Race/Ethnicity: A Validation Study.

Comparison of benefit-risk assessment methods for prospective monitoring of newly marketed drugs: a simulation study.

Community pharmacy automatic refill program improves adherence to maintenance therapy and reduces wasted medication.

Comparative effectiveness of generic versus brand-name antiepileptic medications.